Herbert Loong: Challenges and opportunities in developing Lung Cancer Advocacy – OncoDaily
Herbert Loong: Challenges and opportunities in developing Lung Cancer Advocacy / advancing lung cancer, advocacy conference, Australia, cancer, cancer care,
Herbert Loong: Challenges and opportunities in developing Lung Cancer Advocacy / advancing lung cancer, advocacy conference, Australia, cancer, cancer care,
Severe hemophilia A is managed with factor VIII replacement or hemostatic products that stop or prevent bleeding. Data on gene therapy with hematopoietic stem-cell (HSC)–based…
Abstract. The Fourth Universal Definition of Myocardial Infarction recommends a classification based on aetiology, in recognition that the underlying patho
Hide glossary Study record managers: refer to the Data Element Definitions if submitting registration or results information.
Nature – A study reporting the results of a clinical trial co-administering the GDF-15-blocking antibody visugromab with the anti-PD-1 antibody nivolumab demonstrates that neutralizing GDF-15…
There are other end-of-life decisions that are highly controversial yet lawful.
How living in the past holds you back from healing.
archived 11 Dec 2024 22:17:15 UTC
Key PointsSDoH affects disease severity in children with SCD (aged 0-6 years) despite evidence-based therapy and health care facility support.Understanding
Health secretary says emergency measures banning sale and supply will be made indefinite after expert advice
Internationally recognized physician-scientist Lauren Averett Byers, M.D., Professor and Thoracic Section Chief of Thoracic/Head and Neck Medical Oncology at…